The process of neutrophil adhesion to and migration through the microvascular endothelium, an early event in the induction of the acute inflammatory response, has been attributed to the generation of extravascular chemoattractants. 
Introduction
Increased adherence of circulating neutrophils to the microvascular endothelium is an essential early event in the initiation of the acute inflammatory response, regularly preceding neutrophil migration through vessel walls and accumulation at sites of tissue injury (1, 2) . For nearly a century, chemotactic factors have been implicated as key participants in the process of leukocyte diapedesis (2) (3) (4) . In vivo, intravascular chemoattractants induce a profound neutropenia with sequestration of neutrophils in the microvasculature, presumably the result of enhanced interaction between neutrophils and the microvascular endothelium (5) (6) (7) (8) . In vitro studies have demonstrated that neutrophil adherence to cultured large vessel endothelial cells (human umbilical vein, bovine aorta, porcine aorta) is increased in the presence of a chemotactic stimulus (either peptide or lipid) (9) (10) (11) (12) (13) (14) (15) (16) (17) . However, the mechanism(s) by which chemotactic factors enhance the adhesive interaction between circulating neutrophils and the microvascular endothelium has not yet been defined.
Nevertheless, significant progress has been made in our understanding of mechanisms of human neutrophil adherence as a result ofthe recent definition ofthe critical role of a family of leukocyte surface adhesive glycoproteins in neutrophil adherence-dependent functions (18, 19) . Termed the Mac-1, LFA-1, p50,95 glycoprotein family by Springer and colleagues (20, 21) or CDw18 by the Second International Workshop on Leukocyte Differentiation Antigens (22) , the family is composed of three structurally and functionally related glycoproteins: Mac-1 (the C3bi complement receptor), LFA-1 (lymphocyte function-associated antigen),' and p 150,95. Each consists of an immunologically distinct alpha subunit that is noncovalently associated with a common beta subunit (20) . The distribution of these glycoproteins is limited to white blood cells and hematopoietic precursor cells (19) . Leukocyte adhesion deficiency, a recently recognized autosomal recessive disorder characterized by recurrent bacterial infections, impaired pus formation, and delayed wound healing, has been attributed to deficiency (or complete absence) of cell surface expression of the Mac-1 adhesive glycoprotein family (reviewed in 19) . Neutrophils from such patients demonstrate abnormalities in adherence-dependent functions in vitro (18, 23) including one report of markedly reduced adherence of neutrophils from two patients to cultured large vessel endothelial cells (bovine aortic and human umbilical vein) compared to that of normal neutrophils, when stimulated by phorbol myristate acetate (PMA) or the calcium ionophore A23187 (24) . In addition, a monoclonal antibody (60.3) to the common beta subunit of the glycoprotein family inhibits normal neutrophils stimulated by a variety of mediators including PMA, A23187, FMLP, leukotriene B4 (LTB4), platelet-activating factor (PAF) and tumor necrosis factor (TNF), from adhering to large vessel endothelial cells (24, 25) .
Thus it has been proposed that the inability of patient neutrophils, when stimulated, to express surface adhesive glycoproteins and thereby increase adherence to microvascular endothelium may account for the failure of patient neutrophils to migrate to sites of inflammation in vivo (24, 26) . Evidence to support this concept further derives from the demonstration that bone marrow transplantation completely restored leukocyte function and reversed symptoms in two patients with leukocyte adhesion deficiency (19, 27) and from animal models in which monoclonal antibody 60.3 inhibited neutrophil adherence to venules and accumulation in rabbit muscle after local application of LTB4 or zymosan-activated serum (28) The biologically active chemotactic fragment of the fifth component of complement (C5a) was purified from human serum by a procedure modified from that of Fernandez and Hugh (32) , as reported previously (14, 33) . LTB4 was generously provided by Dr. Robert Murphy (University of Colorado), kept frozen at -20'C in KRPD with 0.1% HSA at 2 X 10-6 M for a maximum of 2 mo, and diluted in assay buffer before use.
PAF (Avanti Polar Lipids, Inc., Birmingham, AL) and Lyso-PAF (Bachem AG, Bubendorf, Switzerland) were kept frozen at -20'C in KRPD with 0.25% HSA at l0-4 M for a maximum of6 mo and diluted in assay buffer before use.
Isolation and culture ofhuman endothelial cells. Human microvascular endothelial cells were isolated from fresh, healthy, omental adipose tissue (obtained after informed consent) according to the method of Kern et al. (34) and cultured as previously described (31) . Briefly, human omental fat was minced finely, digested in 200 U/ml collagenase, and then filtered through 250 ,m mesh to remove undigested fat and through 30 Mm mesh to separate endothelial clumps from single stromal cells and erythrocytes. Further isolation of endothelial cell clumps was accomplished by gravity sedimentation through 5% BSA. The essentially pure endothelial cells were then plated in MCDB 131 supplemented with 5% FCS (Irvine Scientific, Santa Ana, CA), 10 ng/ml epidermal growth factor, and 1 gg/ml hydrocortisone (both from Sigma Chemical Co., St. Louis, MO), which is a selective culture system for endothelial cells (35) . Primary cultures formed confluent monolayers within 7 d and were characterized by demonstration ofthe typical cobblestone morphology of endothelial cells, the expression of Factor VIII-related antigen and the uptake of acetylated low density lipoprotein using methods described by Kern (34) and Knedler (35) .
Human umbilical vein endothelial cells were harvested by collagenase digestion according to the method of Gimbrone et al. (36) and grown as previously described (14) in supplemented MCDB 131.
Endothelial cells were used in first or second passage only for adherence assays.
Isolation and radiolabeling of neutrophils. Blood samples were drawn from normal donors and from patients with leukocyte adhesion deficiency (patients 1, 4, 6, and 9) after informed consent was obtained, as previously reported (19, 26) . Peripheral blood neutrophils were isolated as previously described (30, 31) using plasma-Percoll gradients and avoiding LPS exposure. In brief, fresh citrated venous blood was centrifuged; the platelet-rich plasma was aspirated and recentrifuged to produce platelet-poor plasma (PPP); and the cell pellet was resuspended in 0.5% dextran to remove contaminating erythrocytes by gravity sedimentation. The leukocytes were then separated by centrifugation through 42%/5 1% discontinuous PPP-Percoll gradients. The neutrophils at the interface ofthe 42% and 5 1% Percoll layers were harvested, washed, and resuspended in KRPD. This preparation method yielded neutrophils that were > 95% pure and > 99% viable by trypan blue exclusion.
Human neutrophils (2 X Preparation of protein-coated plastic wells. Ml 99 tissue culture medium (Hazleton) supplemented with 10% FCS was dispensed in 100-Ml vol into the wells of microtiter tissue culture plates (Costar, Cambridge, MA), and the plates placed in a 370C tissue culture incubator for at least 2 h and then washed before use in adherence assays.
Adherence and antibody inhibition assay. Adherence of neutrophils to monolayers of endothelial cells or to protein-coated plastic was assayed as previously described (14) with minor modification. Briefly, human microvascular or umbilical vein endothelial cells were grown to confluence in microtiter tissue culture wells in supplemented MCDB 131. The monolayers were washed twice before assay and maintained in serum free assay buffer. Triplicate or quadruplicate wells were prepared for each experimental variable to be tested.
After gentle suction aspiration of the assay buffer, 1.5 X I05 "'Inlabeled neutrophils in assay buffer were added to each well followed by an appropriate concentration of stimulus dissolved in assay buffer or assay buffer alone. After incubation for 15 min at 370C in a 5% CO2 humidified tissue culture incubator, the adherent neutrophils were fixed by the addition of 2% glutaraldehyde in PBS, and the nonadherent cells were removed by gently washing twice with assay buffer. The adherent cells were then harvested by thorough swabbing with cottontipped applicators, and the applicators then counted in a gamma counter (Beckman Instruments, Inc., Fullerton, CA). Results were expressed as percent adherence = (cpm harvested)/(cpm added) X 100.
For time course experiments, neutrophils were allowed to presettle in the assay wells for 10 min before the addition of stimulus, as previously described (14) .
For antibody inhibition experiments, unless otherwise indicated, a saturating concentration of antibody (as determined by immunofluorescence flow cytometry) diluted in assay buffer was added to the "'In-labeled neutrophils in the assay wells, at 37°C, 5 min prior to the addition of stimulus.
Monoclonal antibodies. The TSl/l 8 monoclonal antibody that recognizes an antigen on the common beta subunit of Mac-1, LFA-1 and p150,95 (20) was used as the IgG I fraction, purified from ascites fluid as previously described (42) . Anti-Leu-4, IgGl fraction, (Becton Dickinson, Mountain View, CA) was used as a nonbinding control monoclonal antibody. NCD-1, IgG 1 fraction, which binds to stimulated human neutrophils and specifically inhibits chemotaxis and enzyme secretion (43) , was a gift from Dr. Susan Walker (National Jewish Center for Immunology and Respiratory Medicine) and was used as a positive binding control monoclonal antibody.
Immunofluorescenceflow cytometry. For labeling, 1 X 106 neutrophils in assay buffer were incubated with or without an appropriate concentration of stimulus for variable periods of time at 37°C before the addition of an excess of ice-cold blocking buffer (KRPD with 5% bovine serum albumin (fraction V; Sigma)). After an additional wash with cold blocking buffer, cells were incubated on ice with the desired concentration of monoclonal antibody for 10 min, washed twice to remove unbound antibody and then incubated with fluorescein-conjugated (FITC) goat anti-mouse antiserum, IgG fraction at 1.2 mg/ml (Cooper Biomedical, West Chester, PA) for 5 min at 4°C. After two final washes, the cells were suspended in KRPD, kept light protected on ice, and assayed within 1 h of preparation.
Analysis of monoclonal antibody binding to resting and stimulated cells by immunofluorescence flow cytometry was performed using either a cytofluorograph (Ortho Diagnostics, Westwood, MA) equipped with an Ortho 2150 computer or a Epics C system flow cytometer (Coulter Instruments, Hialeah, FL). The (Fig.  1) . Mean baseline spontaneous adhesion (buffer alone) was 30-32.5% and mean stimulated adherence, at maximal doses of mediator, ranged from 48 to 57%, although in some experiments up to 65-70% of the neutrophils were induced to adhere to endothelial cells. Mean neutrophil responses were similar for both mediators on both types of endothelium (as well as on protein-coated plastic, data not shown), although considerable donor-to-donor variability was seen when individual experiments were compared, analogous to that reported previously for chemotactic peptides (14) . Under the same experimental conditions, Lyso-PAF, the biologically inactive precursor/metabolite of PAF, failed to enhance neutrophil adherence, even at as high a dose as 10-6 M.
The degree of neutrophil adherence to all three substrata (monolayers of HMVEC and HUVEC as well as proteincoated plastic) induced by the lipid mediators LTB4 and PAF was comparable to that induced by the chemotactic peptides FMLP and C5a to these surfaces. Fig. 2 illustrates the results obtained for all four mediators on the three substrata at two stimulatory concentrations: l0-9 and 10-7 M. Time course experiments (Fig. 3) , in which the time delay required for neutrophils to settle onto the surface of the assay wells was averted by permitting the cells to presettle for 10 (Fig. 7) . In contrast, neutrophil surface glycoprotein expression in buffer alone was approximately twice that of the HL-60 cells and increased substantially upon stimulation, as described above. Likewise, HL-60 cells failed to increase adherence to protein-coated plastic or to HUVEC monolayers when incubated with FMLP or LTB4, in contrast to the typical enhanced adherence response of stimulated neutrophils.
Time course ofstimulated surface glycoprotein expression and stimulated adherence. Although stimulation of neutrophils with either chemotactic peptides or lipid mediators resulted in both increased surface expression ofthe glycoprotein family and in enhanced adherence to substrata, it was not clear whether a causal relationship might exist between the two, e.g., did upregulation of surface expression precede adherence in time and did the degree ofsurface expression correlate with the degree of adherence?
To begin to address this question, the time course ofstimulated surface glycoprotein expression was compared directly with the time course of stimulated adherence. Both time course experiments were performed concomitantly using neutrophils isolated at room temperature from a normal donor according to our usual procedure. Fig. 8 
Discussion
In this study, we have demonstrated that chemotactic peptides, FMLP and C5a, and lipid mediators, LTB4 and PAF, increased adherence of neutrophils in vitro to human microvascular endothelial cells. These mediators, which are believed to participate in the inflammatory response in vivo, have been previously shown to increase neutrophil adherence to a variety of substrata including large vessel endothelial cells in vitro (9) (10) (11) (12) (13) (14) (15) and to enhance interaction of leukocytes with the microvasculature in vivo (48-51). Our observations document that an adhesive interaction between neutrophils and human microvascular endothelial cells may indeed be directly induced by physiologically relevant chemotactic stimuli. This is significant in view of the commonly held belief that endothelial cells may vary in phenotype and function depending on their species of origin, on their in situ location, and on the size and nature of the vessel which they line (31, (52) (53) (54) . Although the microvascular endothelial cells used in our studies were isolated from human omental fat, a site which does not often participate clinically in inflammatory events, we have determined that neutrophils do adhere to and migrate through the microvasculature ofthe omentum in vivo when a C5a preparation is introduced into the abdominal cavity of a rabbit (our unpublished observations). The rapid onset (maximal response within 2 min) of adherence stimulated by the lipid mediators was comparable to that previously reported by us for chemotactic peptides (14) and presumably is necessary to achieve appropriate neutrophil localization near a site oftissue (18, 23) . Since this disorder is characterized by recurrent soft tissue bacterial infections with impaired pus formation, it has been postulated that the failure of patient neutrophils to be recruited to sites of tissue injury might be the result of a basic defect in the ability of the neutrophils, once stimulated, to adhere to the microvascular endothelium (24, 26) . In support of this concept, neither PMA nor calcium ionophore (A23 187) increased adherence of neutrophils from two patients to cultured large vessel endothelial cell monolayers (24) Of interest is the fact that patient neutrophils, in the absence of added stimulus, adhere to endothelial cells to a degree comparable to the spontaneous adhesion of normal control neutrophils (24, 56 , and this report). Buchanan and colleagues (56) also found that the rise in neutrophil count in response to the in vivo administration of epinephrine (considered to be an indicator of the presence of a marginated neutrophil pool) was normal in one patient. In addition, spontaneous (nonstimulated) adherence of normal neutrophils was not inhibited by TS1/18 (this report) or by 60.3 (24) . Taken together, these observations suggest that margination, believed to be a reversible, spontaneous interaction of nonstimulated neutrophils with the vascular endothelium, occurs independently of the glycoprotein family, but that surface expression of the adhesive glycoproteins is essential for neutrophils, once stimulated with inflammatory mediators, to increase adherence to the microvascular endothelium before diapedesis. (45, (58) (59) 61) . Absolute quantitation of stimulus-induced increases in cell surface expression has been difficult due to the fact that cell preparative procedures can lead to temperature-dependent increases in surface expression (44, 45, 59) . It was to be expected, therefore, that our neutrophil isolation technique and the conditions of our adherence assay, involving a 1 5-min incubation at 370C, would result in measurable expression of the glycoprotein family on the neutrophil surface in the absence of added stimuli. As assessed by binding of TSl/ 18, such expression involving the entire population of cells indeed occurred, but to a variable extent, depending in part upon the individual donor and the day of isolation. Of significance, however, was the documentation that further upregulation occurred upon neutrophil stimulation with chemotactic factors, and was dose dependent, with two-to fourfold increases over baseline at optimal concentrations of stimulus. In addition, the concentration range of stimulus which resulted in enhanced surface expression correlated with the concentration range that induced increased neutrophil adherence. Berger et al. (59) previously documented a temperature-dependent increase in the availability of the C3bi complement receptor (CR3, Mac-1) on the surface of an entire population of isolated nonstimulated human neutrophils, the extent of which varied among individuals and among preparations, but could be enhanced threefold by the addition of FMLP.
Nevertheless, evidence is slowly accumulating to question whether stimulus-induced upregulation and increased surface expression are required for enhanced adherence. Although temperature-dependent upregulation of surface glycoproteins occurs during routine isolation of neutrophils, unstimulated neutrophils do not aggregate (65) or avidly adhere to endothelial cells (this report), and the spontaneous endothelial adhesion which occurs cannot be inhibited by TS 1/18 (see above).
Preliminary reports also suggest that stimulus-induced upregulation of surface glycoprotein expression and stimulus-induced adherence-dependent cell functions can be dissociated. We report here lack of correlation in the time courses of upregulation and adherence. Maximal stimulated neutrophil adherence occurred within 1 to 2 min, while cell surface glycoprotein expression increased gradually over 15 min, and at 1-2 min did not exceed the level detectable on unstimulated neutrophils. A comparable dissimilarity has been noted in the time courses of stimulated neutrophil aggregation and glycoprotein upregulation (65) . In addition, the anion channelblocking agent DIDS (4,4'-diisothiocyanostilbene-2,2'-disulfonic acid), which is known to inhibit neutrophil degranulation, reduced the increased glycoprotein surface expression occurring after neutrophil stimulation and inhibited stimulated neutrophil aggregation but not stimulated neutrophil adherence to endothelium (60) . These data, taken together, support the concept that upregulation may not be the only regulatory event, but that once adhesive glycoprotein molecules are expressed on the cell surface, a subsequent modification(s), perhaps a conformational or biochemical change, an interaction with another membrane component or possibly an alter-ation of density distribution of the glycoproteins within the membrane (66) may be required to produce the actual adhesive site. Investigations directed at probing the functional domains of the membrane adhesive glycoproteins have begun (42, 62, 67) and may prove to be instructive in this regard.
Recently it has been reported that a human promyelocytic leukemia cell line, HL-60, in the undifferentiated state has detectable levels ofthe LFA-1 alpha subunit but not the Mac-1 alpha subunit and little or none of the p 150,95 alpha subunit of the glycoprotein family expressed on the cell membrane. Brief stimulation with PMA failed to induce more surface glycoprotein expression (46, 47) . In our studies, neither chemotactic peptide nor lipid mediator stimulation of HL-60 cells increased surface glycoprotein expression or enhanced adherence to endothelial cells. Thus as with patient neutrophils, stimulated adherence failed to occur in the absence of sufficient cell surface glycoprotein expression.
Considerable evidence now documents the involvement of the Mac-1, LFA-1, p150,95 family ofadhesive glycoproteins in the adherence ofneutrophils to endothelium in the presence of a variety of mediators of inflammation, possibly mediated by several different mechanisms. Chemotactic factors stimulate neutrophils to increase adherence to a similar degree to a wide variety of biologic substrata, both living and inert, including human umbilical vein endothelial cells, human dermal fibroblasts, human umbilical vein smooth muscle cells, proteincoated plastic (14) and HMVEC (this report), which appears to occur by a common mechanism requiring expression of the glycoprotein family on the neutrophil surface. The relative nonspecificity with regard to biologic substrata supports the concept that chemotactic factors act primarily on the neutrophil to effect enhanced adherence, as previously proposed (14) . In contrast, IL-1, TNF, thrombin and LTC4 induce cultured human umbilical vein endothelial cells to increase their adhesivity for neutrophils by mechanisms dependent only in part on the glycoprotein family since monoclonal antibodies to the beta subunit also inhibit such adherence, but not to the same degree as inhibition of chemotactic factor-stimulated neutrophil adherence to nonactivated endothelial cells (25, 63, 64, our 
unpublished observations).
Thus, in this report, we demonstrate that both chemotactic peptides and lipid mediators enhance neutrophil adherence to HMVEC, as well as to HUVEC, in a dose-dependent manner with a rapid time course. Stimulated neutrophil adherence to human endothelial cells is dependent on cell surface expression of the Mac-I, LFA-1, p 150,95 glycoprotein family based on the inability of neutrophils from patients with leukocyte adhesion deficiency, as well as HL-60 cells, to be stimulated to adhere, and the ability of a monoclonal antibody specific for the common beta subunit to inhibit stimulated adherence of normal neutrophils. However, since the mechanism(s) involved are as yet unknown, much remains to be explored to further our understanding of the fascinating but complex interaction of circulating neutrophils and the microvascular endothelium during the induction of the acute inflammatory response.
